← Back to all protocols
21

Acute Hyperkalaemia — AdultElectrolyte Emergencies

1 · At a Glance

  • Treat the ECG and the clinical picture, not the lab number alone — ECG changes or haemodynamic compromise mean emergency treatment now, regardless of the exact potassium value.
  • Severity (UK Kidney Association): Normal ≤5.4 · Mild 5.5–5.9 · Moderate 6.0–6.4 · Severe ≥6.5 mmol/L.
  • Any K⁺ ≥6.0 mmol/L → urgent 12-lead ECG.
  • ECG changes present, or K⁺ ≥6.5 mmol/L → give IV calcium immediately, start potassium-shifting therapy (insulin/glucose ± salbutamol), and arrange definitive potassium removal.
  • Calcium does NOT lower potassium — it protects the heart. Insulin/glucose and salbutamol only shift potassium temporarily. Only binders, diuretics and dialysis actually remove potassium from the body.
  • Related EMOnCall protocols: Acute Hypokalaemia — Adult · Acute Hypomagnesaemia — Adult

2 · Immediate Assessment

  • ABCDE approach; assess for haemodynamic instability
  • Continuous cardiac monitoring; obtain a 12-lead ECG urgently
  • Secure IV access
  • If pseudohyperkalaemia is suspected (haemolysed sample, delayed processing, difficult venepuncture, marked leucocytosis/thrombocytosis), send a repeat sample — but do NOT delay emergency treatment if there is severe hyperkalaemia or characteristic ECG changes
  • Consider a venous or arterial blood gas for a rapid potassium result while formal laboratory bloods are pending
  • Check blood glucose, renal function (urea, creatinine, eGFR), bicarbonate/acid–base status, and other relevant investigations (calcium, magnesium, creatine kinase if rhabdomyolysis is suspected)

3 · Severity Classification (UK Kidney Association)

  • Normal: K⁺ ≤5.4 mmol/L
  • Mild: K⁺ 5.5–5.9 mmol/L
  • Moderate: K⁺ 6.0–6.4 mmol/L
  • Severe: K⁺ ≥6.5 mmol/L
  • Treatment decisions depend on more than the number alone — always weigh ECG findings, symptoms, rate of rise (a rise of >0.5 mmol/L in under 12 hours is considered acute/significant), renal function, overall clinical condition, and the underlying cause
  • Local variation: some individual trust protocols use a different continuous-cardiac-monitoring trigger (e.g. ≥7.0 mmol/L) or slightly different action thresholds than the national UKKA bands above — always check local policy alongside this protocol

4 · ECG Features of Hyperkalaemia

  • Tall, peaked T waves (usually the earliest change)
  • PR interval prolongation
  • Flattened or absent P waves
  • Widening QRS complex
  • Bradycardia
  • AV block
  • Ventricular arrhythmias
  • Sine-wave pattern
  • Cardiac arrest (asystole, pulseless electrical activity, or ventricular fibrillation)
  • A normal ECG does NOT exclude dangerous hyperkalaemia — act on the potassium level, clinical context and rate of rise even when the ECG looks reassuring

5 · IV Calcium — Protect the Heart

  • Calcium does NOT lower serum potassium — it stabilises the cardiac cell membrane and reduces the risk of life-threatening arrhythmia; always give it alongside, not instead of, potassium-shifting/removal treatment
  • Indication: any ECG changes of hyperkalaemia, or severe hyperkalaemia (K⁺ ≥6.5 mmol/L) even before ECG changes appear
  • Calcium gluconate 10% (preferred outside cardiac arrest): 30 mL of 10% calcium gluconate IV over 10 minutes via a secure, free-flowing peripheral line — less irritant to tissue than calcium chloride if extravasation occurs
  • Calcium chloride 10% (cardiac arrest / peri-arrest only): 10 mL of 10% calcium chloride IV over 5 minutes — contains roughly three times more elemental calcium per mL than the gluconate salt, but is significantly more irritant; give via the largest available vein, ideally a central line, and flush well
  • Onset and repeat dosing: effect begins within minutes and lasts 30–60 minutes; repeat the ECG after the first dose and repeat the calcium dose if ECG changes persist or recur
  • IV access/extravasation: confirm free flow before injecting and use the most secure cannula available; monitor the injection site closely, especially with calcium chloride, which can cause tissue necrosis if it extravasates
  • Do NOT give calcium and sodium bicarbonate through the same line without flushing thoroughly between them — they precipitate together

6 · Shift Potassium Intracellularly — Insulin + Glucose

  • Dose: 10 units soluble (short-acting) insulin together with 25 g glucose IV — recommended for severe hyperkalaemia (K⁺ ≥6.5 mmol/L) and suggested for moderate hyperkalaemia (K⁺ 6.0–6.4 mmol/L)
  • Check blood glucose before giving. If the pre-treatment glucose is <7.0 mmol/L, follow the insulin/glucose bolus with an infusion of 10% glucose at 50 mL/hour for 5 hours (a further 25 g) to prevent delayed hypoglycaemia
  • Hypoglycaemia precautions: insulin-induced hypoglycaemia is the most common serious complication of this treatment — do not omit the glucose infusion in a patient with a low baseline glucose
  • Blood glucose monitoring schedule: check at 0, 30, 60, 90, 120, 180, 240, 300 and 360 minutes after the insulin/glucose dose (a 6-hour monitoring protocol)
  • Potassium monitoring: effect begins within 15–30 minutes and lasts several hours; recheck serum potassium per the schedule in section 11 — insulin/glucose shifts potassium into cells temporarily, it does not remove it from the body

7 · Shift Potassium Intracellularly — Nebulised Salbutamol

  • Dose: nebulised salbutamol 10–20 mg — note this is substantially higher than the standard bronchodilator dose
  • Role: an adjunct only — recommended alongside insulin/glucose in severe hyperkalaemia, and may be considered as an adjunct in moderate hyperkalaemia
  • Onset: effect begins within 15–30 minutes and lasts around 2 hours
  • Do NOT use salbutamol as a substitute for insulin/glucose in severe hyperkalaemia — it is not effective as monotherapy
  • Cautions: tachycardia and tremor are common; use with caution in significant cardiac ischaemia or tachyarrhythmia; some patients (more often those with renal failure) have a blunted response

8 · Remove Potassium From the Body

  • Insulin/glucose, salbutamol and calcium are temporising measures only — none of them remove potassium from the body; definitive treatment needs one of the options below
  • Sodium zirconium cyclosilicate (SZC): 10 g orally three times daily for up to 72 hours — an option for emergency management of severe hyperkalaemia, and for consideration in moderate hyperkalaemia
  • Patiromer: 8.4 g orally once daily (may be titrated in 8.4 g increments, maximum 25.2 g daily) — an option for moderate or severe hyperkalaemia; not available in Scotland
  • Calcium resonium (calcium polystyrene sulfonate): no longer routinely recommended for acute hyperkalaemia in the current UKKA guideline — removed from the acute treatment pathway in the 2023 update
  • Loop diuretics (e.g. furosemide): may promote urinary potassium loss, but only where renal function and urine output allow — not a substitute for dialysis in significant renal impairment
  • Haemodialysis / renal replacement therapy: the most effective and definitive method of potassium removal, particularly in severe AKI, established renal failure, or hyperkalaemia refractory to medical therapy
  • URGENT RENAL/ICU CONSULTATION AND CONSIDERATION OF DIALYSIS if: severe hyperkalaemia not responding to treatment, significant AKI/oliguria or established renal failure, recurrent or rapidly rising potassium, or any hyperkalaemic cardiac arrest

9 · Cardiac Arrest Due to Hyperkalaemia

  • Distinguish clearly: hyperkalaemia with a pulse is managed as above; hyperkalaemic cardiac arrest needs immediate ALS plus hyperkalaemia-specific treatment given in rapid succession
  • Start standard ALS immediately: continuous chest compressions, early defibrillation for shockable rhythms, adrenaline and standard ALS drugs per usual protocol
  • Calcium: calcium chloride 10% 10 mL IV (preferred in arrest — more elemental calcium per mL) or calcium gluconate 10% 30 mL IV if chloride is unavailable — give as an urgent IV bolus via the largest available line, flushed well
  • Insulin + glucose: 10 units soluble insulin with 25 g glucose IV, given without delay
  • Sodium bicarbonate: 50 mmol sodium bicarbonate IV when hyperkalaemia is known or strongly suspected to be the cause of the arrest — give through a separate line, or flush thoroughly between this and calcium, as they precipitate together if mixed
  • Take a blood gas as soon as possible during the arrest to confirm potassium and guide ongoing treatment
  • Refractory arrest: consider urgent extracorporeal CPR (ECPR)/dialysis in line with local protocols if initial resuscitation is unsuccessful
  • Continue standard post-resuscitation care and arrange urgent renal/ICU involvement and dialysis after ROSC if potassium remains elevated

10 · Identify and Treat the Underlying Cause

  • Common causes: acute kidney injury; chronic kidney disease/established renal failure; ACE inhibitors; angiotensin receptor blockers (ARBs); mineralocorticoid receptor antagonists (e.g. spironolactone); potassium-sparing diuretics; NSAIDs; trimethoprim; potassium supplements; potassium-containing IV fluids; metabolic acidosis; tissue breakdown/rhabdomyolysis; tumour lysis syndrome; haemolysis/pseudohyperkalaemia; adrenal insufficiency; uncontrolled diabetes/insulin deficiency
  • Medication review: stop or withhold potentially causative medications where clinically appropriate — do not simply restart the pre-admission regimen without review
  • Treat any identified precipitant directly (e.g. fluids and source control for AKI, insulin for DKA/HHS, steroids for adrenal insufficiency) alongside potassium-lowering treatment

11 · Monitoring After Treatment

  • Serum potassium: recheck at a minimum of 1, 2, 4, 6 and 24 hours after treatment of moderate or severe hyperkalaemia
  • Blood glucose: monitor at 0, 30, 60, 90, 120, 180, 240, 300 and 360 minutes after insulin/glucose treatment — watch for both early and delayed hypoglycaemia
  • ECG / cardiac rhythm: continuous cardiac monitoring for severe hyperkalaemia (K⁺ ≥6.5 mmol/L per UKKA; some local protocols use ≥7.0 mmol/L — follow the more cautious local policy) or for any ECG changes; repeat the 12-lead ECG after calcium and again as potassium starts to fall
  • Rebound hyperkalaemia: potassium can rise again as the effect of insulin/glucose and salbutamol wears off, typically within a few hours — do not de-escalate monitoring on the strength of an initial improvement alone
  • Delayed hypoglycaemia: risk continues for several hours after insulin — complete the full glucose-monitoring schedule even if the patient is transferred out of the ED

12 · Disposition

  • Continued ED observation: may be appropriate for mild hyperkalaemia with an identified, reversible cause and no ECG changes
  • Hospital admission: generally required for moderate or severe hyperkalaemia, any ECG changes, or where the underlying cause needs inpatient management
  • Monitored / telemetry bed: for ongoing cardiac monitoring after treatment of severe hyperkalaemia or any ECG changes
  • ICU: for hyperkalaemic cardiac arrest, haemodynamic instability, refractory hyperkalaemia, or where dialysis/inotropic/ventilatory support is needed
  • Renal consultation: for significant AKI, CKD, recurrent hyperkalaemia, or need for dialysis
  • Urgent dialysis: for hyperkalaemia refractory to medical therapy, severe AKI/established renal failure, or hyperkalaemic cardiac arrest
  • Disposition should always account for the underlying cause, renal function, response to treatment so far, and the risk of recurrence — not the potassium level in isolation

13 · Quick ED Algorithm

Hyperkalaemia suspected or confirmed
↓
Urgent ECG + continuous cardiac monitoring
↓
ECG changes present, or K⁺ ≥6.5 mmol/L?
↓
Yes → IV calcium (protect the heart) now
↓
Shift potassium: insulin + glucose ± nebulised salbutamol
↓
Remove potassium: SZC / patiromer / loop diuretic if appropriate / dialysis if indicated
↓
Recheck potassium + blood glucose per monitoring schedule
↓
Identify and treat the underlying cause; stop causative medications
↓
Renal/ICU/dialysis if refractory, recurrent, or cardiac arrest occurs

14 · Red Flags — Call for Senior / Renal / ICU Help Now If

  • Potassium at or above the severe threshold (≥6.5 mmol/L)
  • ECG changes of hyperkalaemia
  • Any arrhythmia
  • Haemodynamic instability
  • Rapidly rising potassium
  • Severe AKI or established renal failure
  • Hyperkalaemia refractory to treatment
  • Recurrent hyperkalaemia after apparently successful treatment
  • Suspected need for emergency dialysis
  • Cardiac arrest — treat as hyperkalaemic cardiac arrest (section 9)
← Back to all protocols